Literature DB >> 7548808

Risk factors for ulcerative reflux oesophagitis: a case-control study.

P Ryan1, D J Hetzel, D J Shearman, A J McMichael.   

Abstract

A case-control study was undertaken to investigate the effects of smoking, alcohol consumption, use of non-steroidal anti-inflammatory and other analgesic medications and family and medical history on the risk of ulcerative reflux oesophagitis (URO). We recruited 191 cases with URO diagnosed at endoscopy, 162 hospital controls who had also undergone endoscopy and 140 community controls from the Adelaide metropolitan area. From these three groups of subjects, 134 case-community control pairs, Matched on age, sex and postcode of residence and 142 case-hospital control pairs, matched on age, sex, hospital and endoscopist, were formed. Elevated non-significant risks were found in those smoking at least 20 cigarettes per day relative to those who never smoked (relative risk = 1.9, 95% confidence interval: 0.9-3.9 in case-hospital control pairs; relative risk = 1.9, 95% confidence interval: 0.9-3.7 in case-community control pairs). There was no elevation in risk associated with the use of non-steroidal anti-inflammatory drugs, with alcohol consumption, factors related to medical and reproductive history, nor with family history except for paternal history of heartburn (relative risk = 2.5, 95% confidence interval: 1.2-5.4 in case-hospital control pairs; relative risk = 1.9, 95% confidence interval: 1.0-4.0 in case-community control pairs). With the possible exception of smoking, no other risk factors for ulcerative reflux oesophagitis related to lifestyle are apparent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548808     DOI: 10.1111/j.1440-1746.1995.tb01098.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Anti-inflammatory drugs and variceal bleeding: a case-control study.

Authors:  V De Lédinghen; D Heresbach; O Fourdan; P Bernard; M P Liebaert-Bories; J B Nousbaum; A Gourlaouen; M C Becker; D Ribard; P Ingrand; C Silvain; M Beauchant
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 2.  Functional oesophageal epithelial defense against acid.

Authors:  Yasuhiro Fujiwara; Kazuhide Higuchi; Kazunari Tominaga; Toshio Watanabe; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

3.  Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population.

Authors:  J Kotzan; W Wade; H H Yu
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

4.  Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.

Authors:  T Hayakawa; Y Fujiwara; M Hamaguchi; T Sugawa; M Okuyama; E Sasaki; T Watanabe; K Tominaga; N Oshitani; K Higuchi; T Arakawa
Journal:  Gut       Date:  2005-10-06       Impact factor: 23.059

5.  In Vitro and In Vivo Effects of Nonsteroidal Anti-inflammatory Drugs and Aspirin on Rabbit Esophageal Epithelium.

Authors:  Sezgi Kıpçak; Doğa Çağanoğlu; Pelin Ergün; Serhat Bor
Journal:  Turk J Gastroenterol       Date:  2022-03       Impact factor: 1.555

6.  Alcohol drinking and the risk of Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Hashem B El-Serag; Jesper Lagergren
Journal:  Gastroenterology       Date:  2009-02-23       Impact factor: 22.682

7.  Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease.

Authors:  Tawfik Khoury; Amir Mari; Hana Amara; Mohamed Jabaren; Abdulla Watad; Wiliam Nseir; Wisam Sbeit; Mahmud Mahamid
Journal:  Can J Gastroenterol Hepatol       Date:  2019-02-03

8.  Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men.

Authors:  Tomoyuki Akiyama; Masahiko Inamori; Hiroshi Iida; Hironori Mawatari; Hiroki Endo; Kunihiro Hosono; Kyoko Yoneda; Koji Fujita; Masato Yoneda; Hirokazu Takahashi; Ayumu Goto; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2008-12-11       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.